ARTICLE | Clinical News
Kiobrina: Phase III started
August 8, 2011 7:00 AM UTC
Swedish Orphan began a double-blind, placebo-controlled, European Phase III trial in 70 preterm infants <32 weeks of gestational age to evaluate Kiobrina added to preterm formula or pasteurized human ...